Pubblicazioni

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Continuous, low-dose capecitabine for patients with recurrent colorectal cancer

2015 - MEDICAL ONCOLOGY

Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; DâAntonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo